Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 12 | 2016 | 2080 | 1.410 |
Why?
|
Sciatic Neuropathy | 2 | 2013 | 74 | 0.900 |
Why?
|
Peripheral Nervous System Neoplasms | 2 | 2013 | 123 | 0.870 |
Why?
|
Fibromatosis, Aggressive | 2 | 2013 | 118 | 0.860 |
Why?
|
Lipomatosis | 2 | 2013 | 112 | 0.860 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2021 | 15 | 0.790 |
Why?
|
Internship and Residency | 8 | 2016 | 5761 | 0.770 |
Why?
|
Rib Fractures | 1 | 2017 | 130 | 0.540 |
Why?
|
Muscle Neoplasms | 1 | 2016 | 139 | 0.530 |
Why?
|
Bone Diseases | 3 | 2016 | 417 | 0.450 |
Why?
|
Problem-Based Learning | 1 | 2016 | 359 | 0.430 |
Why?
|
Paracentesis | 1 | 2012 | 95 | 0.420 |
Why?
|
Diagnostic Errors | 2 | 2013 | 1253 | 0.410 |
Why?
|
Musculoskeletal System | 1 | 2014 | 175 | 0.400 |
Why?
|
Thoracic Injuries | 1 | 2014 | 270 | 0.400 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1262 | 0.380 |
Why?
|
Medical Errors | 2 | 2016 | 1291 | 0.380 |
Why?
|
Chest Pain | 1 | 2017 | 1112 | 0.360 |
Why?
|
Fluorodeoxyglucose F18 | 8 | 2009 | 2026 | 0.360 |
Why?
|
Retinal Dehydrogenase | 2 | 2019 | 73 | 0.350 |
Why?
|
Bone Neoplasms | 3 | 2017 | 2521 | 0.330 |
Why?
|
Arthritis, Infectious | 1 | 2012 | 363 | 0.330 |
Why?
|
Musculoskeletal Diseases | 2 | 2020 | 580 | 0.320 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 601 | 0.320 |
Why?
|
Choristoma | 1 | 2010 | 213 | 0.320 |
Why?
|
Confidentiality | 1 | 2012 | 610 | 0.320 |
Why?
|
Teaching | 2 | 2013 | 1166 | 0.320 |
Why?
|
Radiography | 4 | 2015 | 6998 | 0.300 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 840 | 0.290 |
Why?
|
Tomography, Emission-Computed | 3 | 2004 | 1144 | 0.280 |
Why?
|
Radiography, Interventional | 2 | 2017 | 1093 | 0.280 |
Why?
|
Barium Sulfate | 1 | 2006 | 180 | 0.270 |
Why?
|
Enema | 1 | 2006 | 141 | 0.270 |
Why?
|
Extremities | 1 | 2011 | 849 | 0.270 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1435 | 0.270 |
Why?
|
Hip Joint | 1 | 2012 | 1000 | 0.270 |
Why?
|
Educational Measurement | 1 | 2012 | 1205 | 0.260 |
Why?
|
Curriculum | 3 | 2015 | 3575 | 0.260 |
Why?
|
Attitude of Health Personnel | 3 | 2015 | 3844 | 0.250 |
Why?
|
Statistical Distributions | 1 | 2004 | 64 | 0.240 |
Why?
|
Information Dissemination | 1 | 2012 | 1106 | 0.240 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2004 | 136 | 0.240 |
Why?
|
Buttocks | 1 | 2004 | 110 | 0.240 |
Why?
|
Pancreas | 1 | 2010 | 1678 | 0.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2014 | 1185 | 0.220 |
Why?
|
Corpus Striatum | 2 | 2019 | 1220 | 0.220 |
Why?
|
Cumulative Trauma Disorders | 1 | 2004 | 146 | 0.220 |
Why?
|
Bicycling | 1 | 2004 | 174 | 0.210 |
Why?
|
Soft Tissue Injuries | 1 | 2004 | 176 | 0.210 |
Why?
|
Gastrointestinal Diseases | 1 | 2010 | 1162 | 0.200 |
Why?
|
Intracranial Thrombosis | 1 | 2022 | 112 | 0.200 |
Why?
|
Receptors, Thromboxane | 1 | 2001 | 31 | 0.200 |
Why?
|
Wounds and Injuries | 1 | 2014 | 2394 | 0.200 |
Why?
|
Thromboxane A2 | 1 | 2001 | 92 | 0.190 |
Why?
|
Clinical Competence | 2 | 2015 | 4671 | 0.190 |
Why?
|
Bone Marrow | 1 | 2011 | 2933 | 0.190 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2004 | 266 | 0.190 |
Why?
|
Computer-Assisted Instruction | 2 | 2013 | 363 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 5 | 2017 | 20055 | 0.170 |
Why?
|
Contrast Media | 3 | 2015 | 5293 | 0.170 |
Why?
|
Lipoma | 1 | 2021 | 335 | 0.160 |
Why?
|
Dyskinesias | 1 | 2019 | 78 | 0.160 |
Why?
|
Receptors, Opioid, mu | 1 | 2019 | 179 | 0.160 |
Why?
|
Liposarcoma | 1 | 2021 | 324 | 0.160 |
Why?
|
Ecchymosis | 1 | 2017 | 32 | 0.150 |
Why?
|
Substantia Nigra | 1 | 2019 | 353 | 0.150 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12948 | 0.150 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2006 | 2185 | 0.150 |
Why?
|
Quality Improvement | 3 | 2017 | 3730 | 0.150 |
Why?
|
Amyloidosis | 1 | 2003 | 789 | 0.150 |
Why?
|
Taxoids | 1 | 2020 | 661 | 0.140 |
Why?
|
Tretinoin | 1 | 2019 | 513 | 0.140 |
Why?
|
Aged, 80 and over | 8 | 2021 | 57650 | 0.130 |
Why?
|
Reproducibility of Results | 7 | 2021 | 19811 | 0.130 |
Why?
|
Radiopharmaceuticals | 6 | 2004 | 2687 | 0.130 |
Why?
|
Posterior Tibial Tendon Dysfunction | 1 | 2015 | 11 | 0.130 |
Why?
|
Retrospective Studies | 11 | 2021 | 76631 | 0.130 |
Why?
|
Humans | 42 | 2023 | 739398 | 0.130 |
Why?
|
Middle Aged | 17 | 2022 | 212863 | 0.130 |
Why?
|
Flatfoot | 1 | 2015 | 55 | 0.120 |
Why?
|
Microtubules | 1 | 2020 | 1088 | 0.120 |
Why?
|
Triiodobenzoic Acids | 1 | 2014 | 123 | 0.120 |
Why?
|
Male | 23 | 2022 | 349022 | 0.120 |
Why?
|
Female | 24 | 2022 | 378853 | 0.120 |
Why?
|
Liver Neoplasms | 2 | 2006 | 4216 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1232 | 0.110 |
Why?
|
Foot Injuries | 1 | 2014 | 148 | 0.110 |
Why?
|
Hematoma | 1 | 2017 | 754 | 0.110 |
Why?
|
Radiology Information Systems | 2 | 2014 | 523 | 0.110 |
Why?
|
Computer Graphics | 1 | 2014 | 360 | 0.110 |
Why?
|
Attitude to Computers | 1 | 2013 | 202 | 0.110 |
Why?
|
Fluoroscopy | 2 | 2016 | 915 | 0.110 |
Why?
|
Deception | 1 | 2013 | 103 | 0.100 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 480 | 0.100 |
Why?
|
Pneumonia | 1 | 2003 | 2102 | 0.100 |
Why?
|
Blood Sedimentation | 1 | 2012 | 232 | 0.100 |
Why?
|
Tendon Injuries | 1 | 2015 | 312 | 0.100 |
Why?
|
Computers, Handheld | 1 | 2013 | 210 | 0.100 |
Why?
|
Radius | 1 | 2014 | 422 | 0.100 |
Why?
|
Remote Consultation | 1 | 2013 | 239 | 0.100 |
Why?
|
Adult | 12 | 2021 | 213394 | 0.100 |
Why?
|
Aged | 13 | 2021 | 162698 | 0.090 |
Why?
|
Synovial Fluid | 1 | 2012 | 394 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2277 | 0.090 |
Why?
|
Authorship | 1 | 2013 | 268 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1673 | 0.090 |
Why?
|
Learning | 1 | 2019 | 1695 | 0.090 |
Why?
|
Outpatients | 1 | 2017 | 1469 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2409 | 0.090 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14740 | 0.090 |
Why?
|
Lung | 2 | 2008 | 9782 | 0.090 |
Why?
|
Patient Preference | 1 | 2016 | 881 | 0.080 |
Why?
|
Trauma Centers | 1 | 2014 | 888 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2012 | 1581 | 0.080 |
Why?
|
Radius Fractures | 1 | 2014 | 497 | 0.080 |
Why?
|
Documentation | 1 | 2014 | 861 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3268 | 0.080 |
Why?
|
Lung Neoplasms | 4 | 2008 | 12985 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2001 | 5076 | 0.080 |
Why?
|
Observer Variation | 3 | 2014 | 2589 | 0.080 |
Why?
|
Research | 1 | 2016 | 2001 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 1 | 2017 | 1359 | 0.080 |
Why?
|
Positron-Emission Tomography | 5 | 2009 | 6361 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6726 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3510 | 0.070 |
Why?
|
Endosonography | 1 | 2010 | 610 | 0.070 |
Why?
|
Publishing | 1 | 2013 | 828 | 0.070 |
Why?
|
Hemorrhage | 1 | 2017 | 3441 | 0.070 |
Why?
|
England | 1 | 2006 | 522 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5148 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1175 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2213 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 35326 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15036 | 0.060 |
Why?
|
Internet | 2 | 2013 | 3048 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2952 | 0.060 |
Why?
|
Cholecystitis | 1 | 2004 | 182 | 0.060 |
Why?
|
Pilot Projects | 1 | 2016 | 8275 | 0.060 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2022 | 67 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 1939 | 0.050 |
Why?
|
Incidental Findings | 2 | 2004 | 690 | 0.050 |
Why?
|
Dopamine | 2 | 2019 | 1597 | 0.050 |
Why?
|
Biopsy | 2 | 2020 | 6722 | 0.050 |
Why?
|
Bacteria | 1 | 2012 | 2106 | 0.050 |
Why?
|
Colonic Polyps | 1 | 2006 | 543 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4035 | 0.050 |
Why?
|
Risk Factors | 5 | 2022 | 71974 | 0.050 |
Why?
|
Encephalitis | 1 | 2004 | 423 | 0.050 |
Why?
|
Ligaments, Articular | 1 | 2023 | 297 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3752 | 0.050 |
Why?
|
Circular Dichroism | 1 | 2001 | 354 | 0.050 |
Why?
|
Software | 1 | 2014 | 4423 | 0.050 |
Why?
|
Breast | 1 | 2009 | 1950 | 0.050 |
Why?
|
Solutions | 1 | 2001 | 426 | 0.050 |
Why?
|
Neutrophils | 1 | 2012 | 3698 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 2028 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2004 | 735 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12120 | 0.040 |
Why?
|
Adolescent | 4 | 2014 | 85405 | 0.040 |
Why?
|
Extracellular Space | 1 | 2001 | 594 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1999 | 389 | 0.040 |
Why?
|
Gamma Rays | 1 | 1999 | 321 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 503 | 0.040 |
Why?
|
United States | 4 | 2013 | 69573 | 0.040 |
Why?
|
Protein Structure, Secondary | 1 | 2001 | 1245 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 10999 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3497 | 0.040 |
Why?
|
Central Nervous System | 1 | 2004 | 1362 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2017 | 365 | 0.030 |
Why?
|
Sclerosis | 1 | 2016 | 210 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2004 | 1474 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 3146 | 0.030 |
Why?
|
Platelet Count | 1 | 2017 | 780 | 0.030 |
Why?
|
Device Approval | 1 | 2015 | 165 | 0.030 |
Why?
|
Ligands | 1 | 2001 | 3311 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3848 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3692 | 0.030 |
Why?
|
Job Application | 1 | 2013 | 39 | 0.030 |
Why?
|
Photochemotherapy | 1 | 1999 | 805 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1999 | 1504 | 0.030 |
Why?
|
Protein Conformation | 1 | 2001 | 4012 | 0.030 |
Why?
|
PubMed | 1 | 2013 | 121 | 0.030 |
Why?
|
Survival Rate | 1 | 2006 | 12761 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2006 | 10961 | 0.030 |
Why?
|
Risk Management | 1 | 2015 | 571 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 1999 | 1734 | 0.030 |
Why?
|
Fracture Healing | 1 | 2014 | 423 | 0.020 |
Why?
|
Models, Molecular | 1 | 2001 | 5460 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2124 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13635 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2014 | 884 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5154 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1480 | 0.020 |
Why?
|
Age Factors | 1 | 2006 | 18349 | 0.020 |
Why?
|
Occupational Health | 1 | 2015 | 808 | 0.020 |
Why?
|
Mice | 3 | 2020 | 81002 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1383 | 0.020 |
Why?
|
Radioisotopes | 1 | 2009 | 502 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2014 | 1423 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29002 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 8977 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 62693 | 0.020 |
Why?
|
Prognosis | 1 | 2006 | 28901 | 0.020 |
Why?
|
Prospective Studies | 2 | 2009 | 53037 | 0.020 |
Why?
|
Animals | 5 | 2020 | 168368 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9122 | 0.020 |
Why?
|
Inflammation | 1 | 2004 | 10534 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14558 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16646 | 0.010 |
Why?
|
Isotope Labeling | 1 | 2004 | 415 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20676 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5959 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1585 | 0.010 |
Why?
|
Molecular Biology | 1 | 2004 | 594 | 0.010 |
Why?
|
Subtraction Technique | 1 | 2004 | 527 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2013 | 2275 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9314 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6452 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2004 | 918 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7274 | 0.010 |
Why?
|
Mammography | 1 | 2009 | 2466 | 0.010 |
Why?
|
Neoplasms | 2 | 2004 | 21507 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15070 | 0.010 |
Why?
|
Brain | 1 | 2004 | 26345 | 0.010 |
Why?
|
Growth Substances | 1 | 1999 | 784 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4211 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1999 | 1096 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2004 | 1318 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1621 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 3913 | 0.010 |
Why?
|
Secondary Prevention | 1 | 1999 | 1516 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4575 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9133 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 56255 | 0.010 |
Why?
|
Mitochondria | 1 | 1999 | 3522 | 0.000 |
Why?
|
Time Factors | 1 | 2008 | 40050 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 19220 | 0.000 |
Why?
|
Apoptosis | 1 | 1999 | 9714 | 0.000 |
Why?
|
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_